Diverse CMOs Target mid-sized pharmaceutical, agrochemical, and biotech companies that require custom bulk compounds and specialty species, leveraging BOC Sciences’ flexibility in quantities from mg to kg and wide packing options to optimize customers' R&D logistics and cost efficiency.

One Stop Value Position BOC Sciences as a one-stop service for drug development needs, emphasizing streamlined workflows from project design to production, which can appeal to firms seeking to reduce vendor management overhead and accelerate timelines.

RNA Conjugation Capitalize on the recent launch of long non-coding RNA services and the XDC bioconjugation platform to pursue opportunities with biotech firms focusing on RNA therapeutics, siRNA delivery, and targeted bioconjugates.

Strategic Partnerships Leverage past and ongoing collaborations with Spaya and participation in industry events to pursue co-development deals, technology licensing, and expanded distribution to scientists via partner ecosystems.

Competitive Pricing Highlight competitive pricing and flexible packing as differentiators when engaging cost-conscious researchers and SMBs in need of scalable chemical sourcing, with a focus on enabling pilot studies and rapid prototyping.